Spain
· Delayed Price · Currency is EUR BME:REN Statistics
Total Valuation
BME:REN has a market cap or net worth of EUR 25.26 million. The enterprise value is 60.66 million.
| Market Cap | 25.26M |
| Enterprise Value | 60.66M |
Important Dates
The next estimated earnings date is Monday, February 24, 2025.
| Earnings Date | Feb 24, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BME:REN has 32.21 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 32.21M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 16.27% |
| Owned by Institutions (%) | 6.01% |
| Float | 19.19M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | 0.43 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -4.92 |
| EV / Sales | 3.14 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -5.74 |
Financial Position
The company has a current ratio of 1.10, with a Debt / Equity ratio of 0.63.
| Current Ratio | 1.10 |
| Quick Ratio | 0.12 |
| Debt / Equity | 0.63 |
| Debt / EBITDA | n/a |
| Debt / FCF | -3.52 |
| Interest Coverage | -1.16 |
Financial Efficiency
Return on equity (ROE) is -18.79% and return on invested capital (ROIC) is -2.01%.
| Return on Equity (ROE) | -18.79% |
| Return on Assets (ROA) | -1.81% |
| Return on Invested Capital (ROIC) | -2.01% |
| Return on Capital Employed (ROCE) | -4.82% |
| Revenue Per Employee | 483,100 |
| Profits Per Employee | -308,125 |
| Employee Count | 43 |
| Asset Turnover | 0.16 |
| Inventory Turnover | 0.48 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -5.06% in the last 52 weeks. The beta is 1.32, so BME:REN's price volatility has been higher than the market average.
| Beta (5Y) | 1.32 |
| 52-Week Price Change | -5.06% |
| 50-Day Moving Average | 0.72 |
| 200-Day Moving Average | 0.77 |
| Relative Strength Index (RSI) | 61.10 |
| Average Volume (20 Days) | 63,075 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BME:REN had revenue of EUR 19.32 million and -12.33 million in losses.
| Revenue | 19.32M |
| Gross Profit | 5.62M |
| Operating Income | -3.50M |
| Pretax Income | -13.32M |
| Net Income | -12.33M |
| EBITDA | -3.21M |
| EBIT | -3.50M |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 1.76 million in cash and 37.17 million in debt, giving a net cash position of -35.41 million or -1.10 per share.
| Cash & Cash Equivalents | 1.76M |
| Total Debt | 37.17M |
| Net Cash | -35.41M |
| Net Cash Per Share | -1.10 |
| Equity (Book Value) | 59.39M |
| Book Value Per Share | n/a |
| Working Capital | 3.79M |
Cash Flow
In the last 12 months, operating cash flow was -8.21 million and capital expenditures -2.37 million, giving a free cash flow of -10.57 million.
| Operating Cash Flow | -8.21M |
| Capital Expenditures | -2.37M |
| Free Cash Flow | -10.57M |
| FCF Per Share | -0.33 |
Margins
Gross margin is 29.07%, with operating and profit margins of -18.09% and -63.78%.
| Gross Margin | 29.07% |
| Operating Margin | -18.09% |
| Pretax Margin | -68.93% |
| Profit Margin | -63.78% |
| EBITDA Margin | -16.59% |
| EBIT Margin | -18.09% |
| FCF Margin | n/a |
Dividends & Yields
BME:REN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -48.80% |
| FCF Yield | -41.87% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BME:REN has an Altman Z-Score of -0.53. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.53 |
| Piotroski F-Score | n/a |